PATENT CLAIM ANALYSIS

Application Number: 15779929
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["548", "435000"]

Abstract:
The present invention provides organic compounds which are capable of releasing carbon monoxide under physiological conditions or pH trigger, and to the use of such compounds for conditioning a cell, tissue or organ, for example, to protect against ischaemic injury during a transplant event.

Claim (Index 12):
The norbornenone compound of Formula 1a or Formula 1b of  claim 10 , wherein:\n each A 1  and A 2  are independently selected from C\u2550O, C\u2550S, C\u2550CR 12 R 13 , S\u2550O, S(\u2550O) 2 , S, NR 14 ; and each A 3  and A 4  are independently selected from CR 14 R 15 , CR 14 , C\u2550O, C\u2550S, C\u2550CR 12 R 13 , S\u2550O, S(\u2550O) 2 , O, S, NR 14 ; and R 12 , R 13 , R 14 , and R 15 , are as defined in  claim 8 .

Metadata:
- Claim Count in Document: 1.0
- Percentile: 93.0
- Lexical Diversity: 1.225
- Patent Class: 548.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['11311731', '11338587', '12643641', '10561153', '11785998']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7723084947822569
- 35 USC 102 Novelty (BERT): 0.5298894736689924
- Combined Prediction Score: 0.7480665926709305
- Mean Citation Score: 294.66267
- Max Citation Score: 354.02344
- Similarity Product: 209.8103233854008

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test